Supernus Resubmits NDA to FDA for Apomorphine Infusion Device to Treat Parkinson’s

By Stephen Nakrosis Supernus Pharmaceuticals resubmitted a new drug application to the Food and Drug Administration for its apomorphine infusion device to…
October 10, 2023